Role of BMI and hormone therapy in melanoma risk: a case–control study

V De Giorgi, A Gori, I Savarese, A D'Errico… - Journal of Cancer …, 2017 - Springer
Background Currently, the association between body mass index (BMI) and hormone
therapies and Cutaneous Melanoma (CM) development is strongly debated. This study was …
被引用次数：34 相关文章

Role of BMI and hormone therapy in melanoma risk: a case-control study

V De Giorgi, A Gori, I Savarese… - Journal of Cancer …, 2017 - search.proquest.com
Background Currently, the association between body mass index (BMI) and hormone
therapies and Cutaneous Melanoma (CM) development is strongly debated. This study was …

Role of BMI and hormone therapy in melanoma risk: a case-control study.

V De Giorgi, A Gori, I Savarese… - Journal of Cancer …, 2017 - search.ebscohost.com
Background: Currently, the association between body mass index (BMI) and hormone
therapies and Cutaneous Melanoma (CM) development is strongly debated. This study was …

Role of BMI and hormone therapy in melanoma risk: a case-control study.

V Giorgi, A Gori, I Savarese, A D'Errico, F Scarfì, F Papi… - 2017 - cabidigitallibrary.org
Background: Currently, the association between body mass index (BMI) and hormone
therapies and Cutaneous Melanoma (CM) development is strongly debated. This study was …

Role of BMI and hormone therapy in melanoma risk: a caseâ control study

V De Giorgi, A Gori, I Savarese, A D'Errico… - JOURNAL OF …, 2017 - cris.unibo.it
Background: Currently, the association between body mass index (BMI) and hormone
therapies and Cutaneous Melanoma (CM) development is strongly debated. This study was …

Role of BMI and hormone therapy in melanoma risk: a case-control study

V de Giorgi, A Gori, I Savarese, A D'Errico… - JOURNAL OF …, 2017 - research.unipg.it
Background: Currently, the association between body mass index (BMI) and hormone
therapies and Cutaneous Melanoma (CM) development is strongly debated. This study was …

Role of BMI and hormone therapy in melanoma risk: a case–control study

V De Giorgi, A Gori, I Savarese, A D'Errico… - JOURNAL OF …, 2017 - flore.unifi.it
BACKGROUND: Currently, the association between body mass index (BMI) and hormone
therapies and Cutaneous Melanoma (CM) development is strongly debated. This study was …

Role of BMI and hormone therapy in melanoma risk: a case-control study.

V De Giorgi, A Gori, I Savarese, A D'Errico… - Journal of Cancer …, 2017 - europepmc.org
Background Currently, the association between body mass index (BMI) and hormone
therapies and Cutaneous Melanoma (CM) development is strongly debated. This study was …

Role of BMI and hormone therapy in melanoma risk: a case-control study

V De Giorgi, A Gori, I Savarese… - Journal of cancer …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Currently, the association between body mass index (BMI) and hormone
therapies and Cutaneous Melanoma (CM) development is strongly debated. This study was …